{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@id": "https://bio.tools/Monsanto",
  "@type": "sc:SoftwareApplication",
  "sc:description": "> CORRECT NAME OF TOOL COULD ALSO BE 'evidence-informed policy-making' | Public health and evidence-informed policy-making | Monsanto Ordered to Pay $289 Million in Roundup Cancer Trial | Monsanto WHO glyphosate ruling cancer | The lawsuit was the first to go to trial alleging that the company’s weedkillers cause cancer. Monsanto faces more than 5,000 similar lawsuits across the United States | It is the most widely used herbicide in the world. It is the main ingredient in their flagship product, Roundup, the bedrock on which their firm has built its economic model, its wealth and its reputation | The Monsanto Papers, Part 2 — Reaping a bitter harvest | In order to save glyphosate, the Monsanto corporation has undertaken an effort to destroy the United Nations' cancer agency by any means possible. Here is part two of an investigation from Le Monde | We've detected unusual activity from your computer network | To continue, please click the box below to let us know you're not a robot",
  "sc:name": "Monsanto",
  "sc:url": "https://www.nytimes.com/2018/08/10/business/monsanto-roundup-cancer-trial.html"
}